To view this email as a web page, go here.

Message below is a paid advertisement. Content is provided by the sponsor.
 
Discover the difference of 12-week* flea and tick protection with Bravecto® Topical Solution for Cats. View in browser
Bravecto Twelve-Week Protection
1 Dose. 12 Weeks.*
Discover the Difference.
SEE THE DIFFERENCE 12-WEEK* FLEA AND TICK PROTECTION WITH BRAVECTO® CAN MAKE IN YOUR HOSPITAL Discover Bravecto
Better pet owner adherence and more visits are just a few ways Bravecto is helping make a difference in veterinary hospitals. That’s because only Bravecto Topical Solution for Cats has killing fleas and ticks on cats all taken care of for 12 weeks* with just one convenient topical dose.1
Start recommending prescription-only 12-week* protection for cats at your hospital.
Bullet-point User-friendly Twist’n’Use™ design makes application simple
Bullet-point Delivers nearly 3X longer protection than any topical treatment
Bullet-point Fewer treatments per year means less stress for pet owners and their cats
Discover the difference 12-week* prescription-only Bravecto can make for your hospital.
THE 12-WEEK* DIFFERENCE
How can 12-week* protection make a difference for your hospital? Find out now.
Discover Bravecto
MSD
*Bravecto Topical Solution for Cats kills fleas, prevents flea infestations, and kills ticks (black-legged tick) for 12 weeks. Bravecto also kills American dog ticks for 8 weeks.
IMPORTANT SAFETY INFORMATION: The most common adverse reactions recorded in clinical trials were vomiting, itching, diarrhea, hair loss, decreased appetite, lethargy, and scabs/ulcerated lesions. Bravecto has not been shown to be effective for 12-weeks' duration in kittens less than 6 months of age. Bravecto is not effective against American dog ticks beyond 8 weeks of dosing. For topical use only. Avoid oral ingestion. The safety of Bravecto has not been established in breeding, pregnant and lactating cats. Use with caution in cats with a history of neurologic abnormalities. Neurologic abnormalities have been reported in cats receiving Bravecto, even in cats without a history of neurologic abnormalities.
VIEW PRESCRIBING INFORMATION
References: 1. Bravecto Topical Solution for Cats [prescribing information]. Madison, NJ: Merck Animal Health; 2016.
To opt-out of future Merck Animal Health communications click here.
Copyright © 2017 Intervet Inc., d/b/a Merck Animal Health, a subsidiary of Merck & Co. Inc. All rights reserved.